Rapid urbanization raises the issue of protecting development interests in net-incremental reduction regions of construction land (NRRCL). Spatial injustice (SI) is one of the key factors for the smooth implementation of construction land reduction (CLR) policies. This study theoretically analyzes the influence of SI on the economic development in CLR saving quota outflow regions, namely, NRRCL, and conducted empirical tests with the difference-in-differences model. The findings reveal that: (1) regional differences in CLR policy promote the transfer of land development rights from NRRCL to net-incremental increase regions of construction land (NIRCL) in economically developed regions, thus resulting in SI; (2) SI limits the economic development of NRRCL; (3) land-use planning negatively impacts economic development in planning reduced-type regions; (4) the off-site realization of spatial justice in the CLR process in suburbs has comparative advantages; (5) in the process of CLR, it is vital to promote the transfer of population from NRRCL to NIRCL to alleviate the negative impact of SI.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915136 | PMC |
http://dx.doi.org/10.3390/ijerph20032560 | DOI Listing |
Appl Environ Microbiol
January 2025
Department of Biological Sciences, Minnesota State University Mankato, Mankato, Minnesota, USA.
Unlabelled: causes bacterial cold-water disease (BCWD) in salmonids and other fish, resulting in substantial economic losses in aquaculture worldwide. The mechanisms uses to cause disease are poorly understood. Despite considerable effort, most strains of have resisted attempts at genetic manipulation.
View Article and Find Full Text PDFCells
December 2024
Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
The NLRP3 inflammasome, plays a critical role in the pathogenesis of rheumatoid arthritis (RA) by activating inflammatory cytokines such as IL1β and IL18. Targeting NLRP3 has emerged as a promising therapeutic strategy for RA. In this study, a multidisciplinary approach combining machine learning, quantitative structure-activity relationship (QSAR) modeling, structure-activity landscape index (SALI), docking, molecular dynamics (MD), and molecular mechanics Poisson-Boltzmann surface area MM/PBSA assays was employed to identify novel NLRP3 inhibitors.
View Article and Find Full Text PDFExpert Rev Pharmacoecon Outcomes Res
January 2025
School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China.
Background: Empirical evidence regarding temporal trends in cost per quality-adjusted life year (QALY) gained remains limited. This study investigates the evolution of cost-effectiveness for diabetes mellitus treatments over time.
Research Design And Methods: We analyzed cost-effectiveness analyses of anti-diabetic pharmaceuticals extracted from the Tufts Medical Center Cost-Effectiveness Analysis Registry (CEAR).
Int J Health Plann Manage
January 2025
Salidat Kairbekova National Research Center for Health Development of the Ministry of Health of the Republic of Kazakhstan, Astana, Republic of Kazakhstan.
The research relevance is determined by the need for rational use of limited resources in the healthcare sector and the importance of implementing the results of scientific research into medical practice to improve the quality of medical care. The study aims to identify key criteria and develop a system for evaluating clinical trials to prioritise the most promising areas based on their practical applicability in healthcare. The expert evaluation method of 17 research projects in the field of clinical medicine funded by government grants, involving 37 experts, was used to achieve the objective.
View Article and Find Full Text PDFJ Am Heart Assoc
January 2025
Janssen Scientific Affairs LLC, a Johnson & Johnson company Titusville NJ USA.
Background: The economic burden of nonvalvular atrial fibrillation (NVAF) is substantial. Many patients with NVAF are obese and manage other health conditions requiring multiple medications. This real-world study compared health care resource use (HRU) and costs for rivaroxaban and warfarin in patients with NVAF who had polypharmacy and obesity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!